XM tillhandahåller inte tjänster till personer bosatta i USA.

Daily Market Comment – Stocks soar as markets look past Omicron; BoC meeting eyed



  • Optimism prevails as investors see glass half full over Omicron threat
  • Asia lifted by Wall Street jump but futures point to some easing in rally
  • FX markets mostly steady, loonie at 2-week high ahead of BoC decision

Fading Omicron risks boost sentiment

Pre-Christmas cheer came early for equity markets as investors celebrated the growing view that the newly discovered Omicron variant is not more dangerous than the Delta strain. Early evidence suggests that Omicron causes less severe illness than the other variants even though it appears to be the most contagious form of Covid yet.

So far, traders have been embracing the slightest bit of positive news about Omicron, welcoming a preliminary study that shows the Pfizer-BioNTech vaccine offers some protection even though it is significantly less than for other variants. News that a new antibody-based treatment drug is effective against the Omicron strain further reinforced hopes that drastic virus restrictions won’t be necessary.

Stocks heading for more gains but momentum is easing

With investors optimistic that the Omicron outbreak won’t significantly dampen the festivities and lead to winter-long lockdowns, risk assets have bounced back from last week’s panic selloff. Even the tech-heavy Nasdaq posted an incredible rally on Tuesday, surging 3%, despite Treasury yields also rebounding quite strongly.

The S&P 500 closed up 2%, while the Dow Jones finished the session 1.4% higher. Asian shares extended the rally today as monetary easing in China lifted sentiment, offsetting the worrying trend of a lengthening list of local property developers missing their debt payment deadlines.

China has announced a series of measures in recent days aimed at reviving the property sector as well as boosting overall growth in the economy. China’s benchmark stock indices were up more than 1% today, though they’ve been lagging their Asian and global peers all year.

In contrast, the Chinese yuan has been steadily firming in recent months, hitting a 3½-year high versus the US dollar today.

In Europe, stocks opened mixed and US e-mini futures were also pointing to some moderation of the upside momentum.

Dollar mixed, loonie holds near highs ahead of BoC

There was a mixed mood in FX markets on Wednesday as the US dollar lacked a clear direction amid some caution ahead of Friday’s CPI data out of the US and the FOMC meeting next week.

The Australian dollar was the only one from the commodity-linked currencies that was able to stretch its advances against the greenback, climbing to a one-week high of $0.7143.

Relief over the Omicron variant not being as dangerous as first feared has been driving the riskier currencies higher this week, with the aussie and loonie being the main beneficiaries of the improving mood.

The Canadian dollar brushed a fresh two-week high at the start of the session before pulling back slightly. The latest robust employment and trade data out of Canada, combined with waning worries about Omicron and soaring oil prices, have strengthened expectations that the Bank of Canada will sound upbeat at its policy meeting today.

The BoC announces its decision at 15:00 GMT and investors will be looking for clues that policymakers are considering bringing forward their rate hike timeline.

Euro and gold inch higher

The New Zealand dollar also turned lower after a positive open on Wednesday. The kiwi’s paltry rebound this week has been disappointing, but sterling’s performance has been even worse. The euro, however, found itself on a steadier footing after staging a surprise bounce-back on Tuesday.

In commodities, gold edged up for a second day, rising towards $1,790/oz amid some geopolitical tensions between the US and Russia over Ukraine. US President Biden held a two-hour video call with Russian president, Vladimir Putin, yesterday, though it’s unclear whether the meeting will lead to a de-escalation of the situation.

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.